Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Chronic Chikungunya Virus Disease.

McCarthy MK, Davenport BJJ, Morrison TE.

Curr Top Microbiol Immunol. 2019 Jan 18. doi: 10.1007/82_2018_147. [Epub ahead of print]

PMID:
30656438
2.

SODB1 is essential for Leishmania major infection of macrophages and pathogenesis in mice.

Davenport BJ, Martin CG, Beverley SM, Orlicky DJ, Vazquez-Torres A, Morrison TE.

PLoS Negl Trop Dis. 2018 Oct 29;12(10):e0006921. doi: 10.1371/journal.pntd.0006921. eCollection 2018 Oct.

3.

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.

Gralinski LE, Sheahan TP, Morrison TE, Menachery VD, Jensen K, Leist SR, Whitmore A, Heise MT, Baric RS.

MBio. 2018 Oct 9;9(5). pii: e01753-18. doi: 10.1128/mBio.01753-18.

4.

Blocking the Exit: CHIKV Neutralizing Antibodies Nip Viral Egress in the Bud.

McCarthy MK, Morrison TE.

Cell Host Microbe. 2018 Sep 12;24(3):328-330. doi: 10.1016/j.chom.2018.08.008.

PMID:
30212644
5.

Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response.

Lucas ED, Finlon JM, Burchill MA, McCarthy MK, Morrison TE, Colpitts TM, Tamburini BAJ.

J Immunol. 2018 Sep 15;201(6):1735-1747. doi: 10.4049/jimmunol.1800271. Epub 2018 Jul 25.

PMID:
30045970
6.

Chikungunya virus impairs draining lymph node function by inhibiting HEV-mediated lymphocyte recruitment.

McCarthy MK, Davenport BJ, Reynoso GV, Lucas ED, May NA, Elmore SA, Tamburini BA, Hickman HD, Morrison TE.

JCI Insight. 2018 Jul 12;3(13). pii: 121100. doi: 10.1172/jci.insight.121100. [Epub ahead of print]

7.

Ross River virus envelope glycans contribute to disease through activation of the host complement system.

Gunn BM, Jones JE, Shabman RS, Whitmore AC, Sarkar S, Blevins LK, Morrison TE, Heise MT.

Virology. 2018 Feb;515:250-260. doi: 10.1016/j.virol.2017.12.022. Epub 2018 Jan 8.

8.

Inflammatory monocytes mediate control of acute alphavirus infection in mice.

Haist KC, Burrack KS, Davenport BJ, Morrison TE.

PLoS Pathog. 2017 Dec 15;13(12):e1006748. doi: 10.1371/journal.ppat.1006748. eCollection 2017 Dec.

9.

Innate immune control of alphavirus infection.

Carpentier KS, Morrison TE.

Curr Opin Virol. 2018 Feb;28:53-60. doi: 10.1016/j.coviro.2017.11.006. Epub 2017 Nov 22. Review.

10.

MUTATIONS IN THE E2 GLYCOPROTEIN AND THE 3' UNTRANSLATED REGION ENHANCE CHIKUNGUNYA VIRUS VIRULENCE IN MICE.

Hawman DW, Carpentier KS, Fox JM, May NA, Sanders W, Montgomery SA, Moorman NJ, Diamond MS, Morrison TE.

J Virol. 2017 Jul 26. pii: JVI.00816-17. doi: 10.1128/JVI.00816-17. [Epub ahead of print]

11.

Identification of Interactions between Sindbis Virus Capsid Protein and Cytoplasmic vRNA as Novel Virulence Determinants.

Sokoloski KJ, Nease LM, May NA, Gebhart NN, Jones CE, Morrison TE, Hardy RW.

PLoS Pathog. 2017 Jun 29;13(6):e1006473. doi: 10.1371/journal.ppat.1006473. eCollection 2017 Jun.

12.

Persistent RNA virus infections: do PAMPS drive chronic disease?

McCarthy MK, Morrison TE.

Curr Opin Virol. 2017 Apr;23:8-15. doi: 10.1016/j.coviro.2017.01.003. Epub 2017 Feb 17. Review.

13.

Animal Models of Zika Virus Infection, Pathogenesis, and Immunity.

Morrison TE, Diamond MS.

J Virol. 2017 Mar 29;91(8). pii: e00009-17. doi: 10.1128/JVI.00009-17. Print 2017 Apr 15. Review.

14.

Animal Models of Chikungunya Virus Infection and Disease.

Haese NN, Broeckel RM, Hawman DW, Heise MT, Morrison TE, Streblow DN.

J Infect Dis. 2016 Dec 15;214(suppl 5):S482-S487. Review.

15.

4EBP-Dependent Signaling Supports West Nile Virus Growth and Protein Expression.

Shives KD, Massey AR, May NA, Morrison TE, Beckham JD.

Viruses. 2016 Oct 18;8(10). pii: E287.

16.

Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence.

Hawman DW, Fox JM, Ashbrook AW, May NA, Schroeder KMS, Torres RM, Crowe JE Jr, Dermody TS, Diamond MS, Morrison TE.

Cell Rep. 2016 Aug 2;16(5):1326-1338. doi: 10.1016/j.celrep.2016.06.076. Epub 2016 Jul 21.

17.

Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.

Ashbrook AW, Lentscher AJ, Zamora PF, Silva LA, May NA, Bauer JA, Morrison TE, Dermody TS.

MBio. 2016 May 24;7(3). pii: e00693-16. doi: 10.1128/mBio.00693-16.

18.

Chronic chikungunya virus musculoskeletal disease: what are the underlying mechanisms?

McCarthy MK, Morrison TE.

Future Microbiol. 2016;11(3):331-4. doi: 10.2217/fmb.15.147. Epub 2016 Mar 4. No abstract available.

19.

Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain.

Beatman EL, Massey A, Shives KD, Burrack KS, Chamanian M, Morrison TE, Beckham JD.

J Virol. 2015 Dec 30;90(6):2767-82. doi: 10.1128/JVI.02949-15.

20.

Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis.

Monin L, Griffiths KL, Lam WY, Gopal R, Kang DD, Ahmed M, Rajamanickam A, Cruz-Lagunas A, Zúñiga J, Babu S, Kolls JK, Mitreva M, Rosa BA, Ramos-Payan R, Morrison TE, Murray PJ, Rangel-Moreno J, Pearce EJ, Khader SA.

J Clin Invest. 2015 Dec;125(12):4699-713. doi: 10.1172/JCI77378. Epub 2015 Nov 16.

21.

Myeloid Cell Arg1 Inhibits Control of Arthritogenic Alphavirus Infection by Suppressing Antiviral T Cells.

Burrack KS, Tan JJ, McCarthy MK, Her Z, Berger JN, Ng LF, Morrison TE.

PLoS Pathog. 2015 Oct 5;11(10):e1005191. doi: 10.1371/journal.ppat.1005191. eCollection 2015 Oct.

22.

The Global Virus Network: Challenging chikungunya.

McSweegan E, Weaver SC, Lecuit M, Frieman M, Morrison TE, Hrynkow S.

Antiviral Res. 2015 Aug;120:147-52. doi: 10.1016/j.antiviral.2015.06.003. Epub 2015 Jun 10. Review.

23.

Noncapped Alphavirus Genomic RNAs and Their Role during Infection.

Sokoloski KJ, Haist KC, Morrison TE, Mukhopadhyay S, Hardy RW.

J Virol. 2015 Jun;89(11):6080-92. doi: 10.1128/JVI.00553-15. Epub 2015 Apr 1.

24.

Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response.

Halemano K, Barrett BS, Heilman KJ, Morrison TE, Santiago ML.

J Virol. 2015 Apr;89(7):4011-4. doi: 10.1128/JVI.03399-14. Epub 2015 Jan 14.

25.

CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected mice.

Burrack KS, Montgomery SA, Homann D, Morrison TE.

J Immunol. 2015 Jan 15;194(2):678-89. doi: 10.4049/jimmunol.1401833. Epub 2014 Dec 8.

26.

The role of myeloid cell activation and arginine metabolism in the pathogenesis of virus-induced diseases.

Burrack KS, Morrison TE.

Front Immunol. 2014 Sep 8;5:428. doi: 10.3389/fimmu.2014.00428. eCollection 2014. Review.

27.

Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.

Ashbrook AW, Burrack KS, Silva LA, Montgomery SA, Heise MT, Morrison TE, Dermody TS.

J Virol. 2014 Nov;88(21):12180-92. doi: 10.1128/JVI.01672-14. Epub 2014 Aug 20.

28.

Reemergence of chikungunya virus.

Morrison TE.

J Virol. 2014 Oct;88(20):11644-7. doi: 10.1128/JVI.01432-14. Epub 2014 Jul 30. Review.

29.

Essential role for the lectin pathway in collagen antibody-induced arthritis revealed through use of adenovirus programming complement inhibitor MAp44 expression.

Banda NK, Mehta G, Kjaer TR, Takahashi M, Schaack J, Morrison TE, Thiel S, Arend WP, Holers VM.

J Immunol. 2014 Sep 1;193(5):2455-68. doi: 10.4049/jimmunol.1400752. Epub 2014 Jul 28.

30.

Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.

Pal P, Fox JM, Hawman DW, Huang YJ, Messaoudi I, Kreklywich C, Denton M, Legasse AW, Smith PP, Johnson S, Axthelm MK, Vanlandingham DL, Streblow DN, Higgs S, Morrison TE, Diamond MS.

J Virol. 2014 Aug;88(15):8213-26. doi: 10.1128/JVI.01032-14. Epub 2014 May 14.

31.

Attenuating mutations in nsP1 reveal tissue-specific mechanisms for control of Ross River virus infection.

Stoermer Burrack KA, Hawman DW, Jupille HJ, Oko L, Minor M, Shives KD, Gunn BM, Long KM, Morrison TE.

J Virol. 2014 Apr;88(7):3719-32. doi: 10.1128/JVI.02609-13. Epub 2014 Jan 15.

32.

A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.

Silva LA, Khomandiak S, Ashbrook AW, Weller R, Heise MT, Morrison TE, Dermody TS.

J Virol. 2014 Mar;88(5):2385-97. doi: 10.1128/JVI.03116-13. Epub 2013 Dec 26.

33.

Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response.

Hawman DW, Stoermer KA, Montgomery SA, Pal P, Oko L, Diamond MS, Morrison TE.

J Virol. 2013 Dec;87(24):13878-88. doi: 10.1128/JVI.02666-13. Epub 2013 Oct 16.

34.

Large spontaneous pneumothorax with relatively minor symptoms.

Morrison TE.

BMJ Case Rep. 2013 May 8;2013. pii: bcr2013009531. doi: 10.1136/bcr-2013-009531. No abstract available.

35.

A tyrosine-to-histidine switch at position 18 of the Ross River virus E2 glycoprotein is a determinant of virus fitness in disparate hosts.

Jupille HJ, Medina-Rivera M, Hawman DW, Oko L, Morrison TE.

J Virol. 2013 May;87(10):5970-84. doi: 10.1128/JVI.03326-12. Epub 2013 Mar 20.

36.

Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus.

Stoermer KA, Burrack A, Oko L, Montgomery SA, Borst LB, Gill RG, Morrison TE.

J Immunol. 2012 Oct 15;189(8):4047-59. doi: 10.4049/jimmunol.1201240. Epub 2012 Sep 12.

37.

Dephosphorylation of HuR protein during alphavirus infection is associated with HuR relocalization to the cytoplasm.

Dickson AM, Anderson JR, Barnhart MD, Sokoloski KJ, Oko L, Opyrchal M, Galanis E, Wilusz CJ, Morrison TE, Wilusz J.

J Biol Chem. 2012 Oct 19;287(43):36229-38. doi: 10.1074/jbc.M112.371203. Epub 2012 Aug 22.

38.

Mannose binding lectin is required for alphavirus-induced arthritis/myositis.

Gunn BM, Morrison TE, Whitmore AC, Blevins LK, Hueston L, Fraser RJ, Herrero LJ, Ramirez R, Smith PN, Mahalingam S, Heise MT.

PLoS Pathog. 2012;8(3):e1002586. doi: 10.1371/journal.ppat.1002586. Epub 2012 Mar 22.

39.

The relationship between prenatal control, expectations, experienced control, and birth satisfaction among primiparous women.

Fair CD, Morrison TE.

Midwifery. 2012 Feb;28(1):39-44. doi: 10.1016/j.midw.2010.10.013. Epub 2011 Apr 1.

PMID:
21458895
40.

A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection.

O'Brien KB, Morrison TE, Dundore DY, Heise MT, Schultz-Cherry S.

PLoS One. 2011 Mar 9;6(3):e17377. doi: 10.1371/journal.pone.0017377.

41.

Complement and viral pathogenesis.

Stoermer KA, Morrison TE.

Virology. 2011 Mar 15;411(2):362-73. doi: 10.1016/j.virol.2010.12.045. Epub 2011 Feb 2. Review.

42.

A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence.

Morrison TE, Oko L, Montgomery SA, Whitmore AC, Lotstein AR, Gunn BM, Elmore SA, Heise MT.

Am J Pathol. 2011 Jan;178(1):32-40. doi: 10.1016/j.ajpath.2010.11.018. Epub 2010 Dec 23.

43.

Mutations in nsP1 and PE2 are critical determinants of Ross River virus-induced musculoskeletal inflammatory disease in a mouse model.

Jupille HJ, Oko L, Stoermer KA, Heise MT, Mahalingam S, Gunn BM, Morrison TE.

Virology. 2011 Feb 5;410(1):216-27. doi: 10.1016/j.virol.2010.11.012. Epub 2010 Dec 4.

44.

SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.

Frieman MB, Chen J, Morrison TE, Whitmore A, Funkhouser W, Ward JM, Lamirande EW, Roberts A, Heise M, Subbarao K, Baric RS.

PLoS Pathog. 2010 Apr 8;6(4):e1000849. doi: 10.1371/journal.ppat.1000849.

45.

Modulation of type I IFN induction by a virulence determinant within the alphavirus nsP1 protein.

Cruz CC, Suthar MS, Montgomery SA, Shabman R, Simmons J, Johnston RE, Morrison TE, Heise MT.

Virology. 2010 Mar 30;399(1):1-10. doi: 10.1016/j.virol.2009.12.031. Epub 2010 Jan 25.

46.

Venezuelan equine encephalitis virus disrupts STAT1 signaling by distinct mechanisms independent of host shutoff.

Simmons JD, White LJ, Morrison TE, Montgomery SA, Whitmore AC, Johnston RE, Heise MT.

J Virol. 2009 Oct;83(20):10571-81. doi: 10.1128/JVI.01041-09. Epub 2009 Aug 5.

47.

CCAAT/enhancer binding proteins alpha and beta regulate the tumor necrosis factor receptor 1 gene promoter.

Bristol JA, Morrison TE, Kenney SC.

Mol Immunol. 2009 Aug;46(13):2706-13. doi: 10.1016/j.molimm.2009.05.024. Epub 2009 Jun 11.

48.

MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.

Sheahan T, Morrison TE, Funkhouser W, Uematsu S, Akira S, Baric RS, Heise MT.

PLoS Pathog. 2008 Dec;4(12):e1000240. doi: 10.1371/journal.ppat.1000240. Epub 2008 Dec 12.

49.

Complement receptor 3 promotes severe ross river virus-induced disease.

Morrison TE, Simmons JD, Heise MT.

J Virol. 2008 Nov;82(22):11263-72. doi: 10.1128/JVI.01352-08. Epub 2008 Sep 10.

50.

The host complement system and arbovirus pathogenesis.

Morrison TE, Heise MT.

Curr Drug Targets. 2008 Feb;9(2):165-72. Review.

PMID:
18288968

Supplemental Content

Loading ...
Support Center